[Pharmacological studies of ketoprofen (19583RP) III. Anti-inflammatory, analgesic and antipyretic actions in subcutaneous administration (author's transl)]. 1977

K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura

It has been already reported that ketoprofen (KP) has a potent anti-inflammatory action comparable to indomethacin, but with oral administration, gastric mucous membrane disturbances occur. In the present work, we administered the Na salt of KP (KP-Na) subcutaneously and found that the anti-inflammatory action was more potent in subacute and chronic inflammations than in the acute one. As an acidic compound, KP-Na had a relatively potent analgesic-antipyretic action and a medical efficacy comparable to the usual non-steroidal anti-inflammatory drugs given orally. The efficacy in case of subcutaneous administration was 2 to 3 times stronger over both acute and chronic inflammations than in case of oral administration. On the other hand, the gastric mucous membrane disturbance was decreased to about 1/3 in case of subcutaneous administration, thus the gastric disturbance could be abated and the medical efficacy can be increased when KP-Na is given subcutaneously. As KP-Na was less irritative at the injection site, the compound could be used clinically for a subcutaneous administration.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008297 Male Males
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D004890 Erythema Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes. Erythemas
D005260 Female Females

Related Publications

K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
July 1974, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
January 1972, Chemical & pharmaceutical bulletin,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
April 1976, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
March 1977, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
October 2004, Biological & pharmaceutical bulletin,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
May 1971, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
March 1969, Archives internationales de pharmacodynamie et de therapie,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
January 1965, Therapie,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
March 1982, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
K Tsurumi, and M Nozaki, and K Nakano, and K Go, and H Fujimura
January 1980, Voprosy onkologii,
Copied contents to your clipboard!